Market Overview

JP Morgan Maintains Overweight on Rigel Pharmaceuticals, Inc., Lowers PT to $10.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for RIGL

DateFirmActionFromTo
Sep 2016JefferiesMaintainsBuy
Aug 2016BMO CapitalMaintainsOutperform
Aug 2016BMO CapitalInitiates Coverage onOutperform

View More Analyst Ratings for RIGL
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (RIGL)